Written Question·Department of Health and Social Care·UIN 106402
Liver Diseases: Nottinghamshire
Tabled: 16 January 2026
Answered: 2 March 2026
Question
Steve Yemm
Labour — Mansfield
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of trends in the number of patients with metabolic dysfunction–associated steatohepatitis on the NHS in (a) Nottinghamshire and (b) Mansfield con
Answer
Ashley DaltonData on hospital admission rates for metabolic dysfunction-associated steatotic liver disease (MASLD), of which metabolic dysfunction–associated steatohepatitis is a stage in some cases, is available at the Department’s Fingertips website, and can be used...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 106402) →